PotentIn VitroAntibacterial Activity of DS-8587, a Novel Broad-Spectrum Quinolone, against Acinetobacter baumannii

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Characteristic Resistance Mechanism ofMycobacterium tuberculosisto DC-159a, a New Respiratory Quinolone

(2011) Jun-ichiro Sekiguchi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the TigecyclineIn VitroSurveillance in Taiwan Study, 2006 to 2010

(2011) Yen-Hsu Chen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.

(2010) Sébastien Coyne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance

(2010) Nicola C. Gordon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii

(2010) M. Hornsey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CraA, a Major Facilitator Superfamily Efflux Pump Associated with Chloramphenicol Resistance in Acinetobacter baumannii

(2009) I. Roca et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistantPseudomonas aeruginosaandAcinetobacter baumannii: resistance mechanisms and implications for therapy

(2009) Alexandre P Zavascki et al.   Expert Review of Anti-Infective Therapy

Triclosan resistance in clinical isolates of Acinetobacter baumannii

(2009) Y. Chen et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Correlation of Antimicrobial Resistance with  -Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City

(2008) S. Bratu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Acinetobacter baumannii:an emerging multidrug-resistant threat

(2008) Thomas D Gootz et al.   Expert Review of Anti-Infective Therapy

Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae

(2008) R. Okumura et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY